Intelligence / Healthtech / PMA Approvals / Spineart USA, INC.
Approvalsdevice change approved (PMA)22 Sept 2026
Spineart USA, INC.
22 Sept 2026: Device change approved (PMA) · BAGUERA®C Cervical Disc Prosthesis. Recorded in the openFDA device PMA data.
- Decided
- 22 Sept 2026
- Device
- BAGUERA®C Cervical Disc Prosthesis
- Specialty
- Orthopedic
- Type
- Supplement (Normal 180 Day Track No User Fee)
- Reason
- Postapproval Study Protocol
- Reference
- P250042 S002
- Location
- Laguna Hills, CA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Spineart USA, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Orthopedic
PMA Approvals
21 SeptDepuy, INC.device change approved (PMA) · Attune Revision Knee SystemApprovals9 SeptCentinel Spine, LLCdevice change approved (PMA) · prodisc® C NovaApprovals26 AugMedtronic Sofamor Danek USA, INC.device change approved (PMA) · INFUSE BONE GRAFTApprovals26 AugMedtronic Sofamor Danek USA, INC.device change approved (PMA) · INFUSE BONE GRAFT/LT-CAGE LUMBAR TAPERED FUSION DEVICEApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.